The trial enrolled 80 women aged 45 and older diagnosed with breast cancer who were about to start neoadjuvant chemotherapy (NCT), a type of chemo given before surgery to shrink tumors. Participants were randomly assigned to receive either 2,000 IU of vitamin D daily or a placebo for six months, during their chemotherapy treatment.
Similar Posts
When It Comes to AI, Rural Doctors Have FOMO — Meditech & Suki Are Teaming Up to Address This – MedCity News
Most rural hospitals simply don’t have the resources to adopt AI at the same rate as…
How Badly Would Medicaid Cuts Hurt Healthcare Access in Rural America
The Trump administration’s flagship budget package, dubbed the One Big Beautiful Bill Act, is advancing through…
How Much Does A Gastric Bypass Cost?
How Much Does a Gastric Bypass Cost? Would you believe that over 40% of adults in…
4 Announcements GE HealthCare Made at RSNA 2024
The Radiological Society of North America is hosting its annual meeting in Chicago this week, bringing…
Lip-Smacking Winter-Special Vegetarian Recipes
With the arrival of winter, we start craving hot, sweet, and savory seasonal delights. Be it…
The Digital Shift: How Telemedicine Is Changing Physician Job Opportunities
In recent years, advancements in technology have brought about changes across various sectors, with healthcare being…
